MedTrace Logo

Study of the ICG Distribution in the Margins of Breast Cancer After Tumorectomy

NCT02027818 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-12-15

No results posted yet for this study

Summary

We will observe if ICG fluorescence correlates with margins of breast tumours after iv injection of the contrast agent

Conditions

Interventions

DRUG

Indocyanine Green

Observation of the correlation between fluorescence and margins of the tumour after IV injection of ICG

Sponsors & Collaborators

  • Jules Bordet Institute

    lead OTHER

Principal Investigators

  • Danièle Noterman, MD · Jules Bordet Institute

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02027818 on ClinicalTrials.gov